Trial Profile
Comparative Study of Safety and Efficacy Between 100 U Suburothelial Injection and 50 U Suburothelial Plus 50 U Urethral Injections of Botulinum Toxin A in Treatment of Patients With Detrusor Overactivity and Impaired Contractility
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Feb 2017
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary) ; Botulinum-Toxin-A (Primary)
- Indications Overactive bladder
- Focus Adverse reactions; Therapeutic Use
- 14 Feb 2017 Status changed from recruiting to completed.
- 23 Jul 2014 New trial record